BIVI
Price
$1.95
Change
+$0.12 (+6.56%)
Updated
Oct 13 closing price
Capitalization
14.7M
INNMF
Price
$0.11
Change
-$0.02 (-15.38%)
Updated
Oct 13 closing price
Capitalization
49.82M
Interact to see
Advertisement

BIVI vs INNMF

Header iconBIVI vs INNMF Comparison
Open Charts BIVI vs INNMFBanner chart's image
BioVie
Price$1.95
Change+$0.12 (+6.56%)
Volume$166.63K
Capitalization14.7M
Amplia Therapeutics
Price$0.11
Change-$0.02 (-15.38%)
Volume$20K
Capitalization49.82M
BIVI vs INNMF Comparison Chart in %
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIVI vs. INNMF commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVI is a Hold and INNMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 14, 2025
Stock price -- (BIVI: $1.95 vs. INNMF: $0.11)
Brand notoriety: BIVI and INNMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIVI: 58% vs. INNMF: 55%
Market capitalization -- BIVI: $14.7M vs. INNMF: $49.82M
BIVI [@Biotechnology] is valued at $14.7M. INNMF’s [@Biotechnology] market capitalization is $49.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIVI’s FA Score shows that 1 FA rating(s) are green whileINNMF’s FA Score has 1 green FA rating(s).

  • BIVI’s FA Score: 1 green, 4 red.
  • INNMF’s FA Score: 1 green, 4 red.
According to our system of comparison, INNMF is a better buy in the long-term than BIVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 3 TA indicator(s) are bullish while INNMF’s TA Score has 3 bullish TA indicator(s).

  • BIVI’s TA Score: 3 bullish, 3 bearish.
  • INNMF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BIVI is a better buy in the short-term than INNMF.

Price Growth

BIVI (@Biotechnology) experienced а +4.28% price change this week, while INNMF (@Biotechnology) price change was +10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +80.86%.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INNMF($49.8M) has a higher market cap than BIVI($14.7M). INNMF YTD gains are higher at: 166.344 vs. BIVI (-90.250). INNMF has higher annual earnings (EBITDA): -6.43M vs. BIVI (-16.98M). BIVI has more cash in the bank: 17.5M vs. INNMF (10.9M). INNMF has less debt than BIVI: INNMF (13.9K) vs BIVI (350K).
BIVIINNMFBIVI / INNMF
Capitalization14.7M49.8M30%
EBITDA-16.98M-6.43M264%
Gain YTD-90.250166.344-54%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash17.5M10.9M161%
Total Debt350K13.9K2,518%
FUNDAMENTALS RATINGS
BIVI vs INNMF: Fundamental Ratings
BIVI
INNMF
OUTLOOK RATING
1..100
6228
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
32
Undervalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
9641
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIVI's Valuation (11) in the null industry is in the same range as INNMF (32). This means that BIVI’s stock grew similarly to INNMF’s over the last 12 months.

INNMF's Profit vs Risk Rating (90) in the null industry is in the same range as BIVI (100). This means that INNMF’s stock grew similarly to BIVI’s over the last 12 months.

INNMF's SMR Rating (97) in the null industry is in the same range as BIVI (99). This means that INNMF’s stock grew similarly to BIVI’s over the last 12 months.

INNMF's Price Growth Rating (41) in the null industry is somewhat better than the same rating for BIVI (96). This means that INNMF’s stock grew somewhat faster than BIVI’s over the last 12 months.

INNMF's P/E Growth Rating (100) in the null industry is in the same range as BIVI (100). This means that INNMF’s stock grew similarly to BIVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIVIINNMF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYBR504.0210.50
+2.13%
CyberArk Software Ltd
VSEC157.732.77
+1.79%
VSE Corp
BSLK3.630.05
+1.40%
Bolt Projects Holdings Inc
ACET0.980.01
+1.25%
Adicet Bio
TERN8.200.05
+0.61%
Terns Pharmaceuticals

BIVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with HURA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
+6.56%
HURA - BIVI
53%
Loosely correlated
+1.67%
HOFBF - BIVI
44%
Loosely correlated
N/A
LGVN - BIVI
37%
Loosely correlated
-1.54%
SCNI - BIVI
34%
Loosely correlated
-0.73%
CMMB - BIVI
30%
Poorly correlated
+2.44%
More

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
-14.46%
BIVI - INNMF
26%
Poorly correlated
+6.56%
HOFBF - INNMF
23%
Poorly correlated
N/A
CYTK - INNMF
23%
Poorly correlated
-0.75%
PHRRF - INNMF
20%
Poorly correlated
+12.41%
IVEVF - INNMF
15%
Poorly correlated
N/A
More